Led by Prof. Mary Bryson, Director of the Institute for Gender, Race, Sexuality and Social Justice, and funded by the Canadian Institutes for Health Research, the three-year Cancer’s Margins project will look at how lesbian, gay, bisexual and transgender cancer patients and members of their support networks in British Columbia, Manitoba, Ontario, Quebec, and Nova Scotia experience breast and gynecological cancers from screening and diagnosis to care, treatment and support networks.
Researchers want to understand what individuals value about their care and support networks, how they educate themselves, and what they consider culturally competent care.
“People try to look for health information in communities that reflect themselves,” said Bryson, also a professor in the Faculty of Education.
“We’ve found that these groups don’t have access to cancer health care, or cancer support communities that map onto their own support networks and community values.”
According to Statistics Canada, LGBT people are less likely to have a general practitioner and therefore to participate in cancer screening. Canadian GP’s typically have little or no knowledge of the cancer risks these populations face.
According to Bryson, the LGBT experience with breast and gynecological cancers is unique in that typical cancer screening initiatives, cancer treatment and support protocols don’t anticipate the inclusion of sexual minorities.
“A transgender man may still be at risk for developing gynecologic cancers but he may not be participating in regular screening because none of the health promotions and awareness material is directed at him and his GP may be unaware of his risk.”
For more information, visit the Cancer’s Margins website at: www.queercancer.org.
Cancer’s Margins research will be conducted through interviews with cancer patients and members of their support networks in British Columbia, Manitoba, Ontario, Quebec, and Nova Scotia. The project will also bring to light the experiences of those who are doubly marginalized by speaking to LGBT Aboriginals, Francophones, members of racialized communities, and those living in Northern and remote locations. Cancer’s Margins is being conducted with collaborators at all the major community and cancer health organizations across Canada including the BC Cancer Agency, Canadian Cancer Society, the Canadian Women’s Health Network, Breast Cancer Action, Ovarian Cancer Canada, Canadian Breast Cancer Network, and many others.
The Canadian Institutes of Health Research (CIHR) is the Government of Canada’s health research investment agency. CIHR’s mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened Canadian health care system. Composed of 13 Institutes, CIHR provides leadership and support to more than 14,100 health researchers and trainees across Canada.